Connection

Bryan Tolliver to Adult

Back to Details
This is a "connection" page, showing publications Bryan Tolliver has written about Adult.
Bryan Tolliver
Connection Strength
0.473
Adult
  1. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders. Addict Biol. 2022 01; 27(1):e13085.
    View in: PubMed
    Score: 0.054
  2. A Multimethod Examination of Sensitivity to Reward and Sensitivity to Punishment in Bipolar Disorder and Alcohol Dependence: Results from a 2 ? 2 Factorial Design. Psychopathology. 2021; 54(2):70-77.
    View in: PubMed
    Score: 0.052
  3. An evaluation of the impact of co-occurring anxiety and substance use disorder on bipolar disorder illness outcomes in STEP-BD. J Affect Disord. 2019 03 01; 246:794-799.
    View in: PubMed
    Score: 0.045
  4. An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD). J Affect Disord. 2016 Nov 15; 205:73-80.
    View in: PubMed
    Score: 0.038
  5. Evidence for the continuous latent structure of mania and depression in out-patients with bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychol Med. 2015; 45(12):2595-603.
    View in: PubMed
    Score: 0.035
  6. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2012 Feb; 14(1):54-63.
    View in: PubMed
    Score: 0.028
  7. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res. 2012 Mar; 36(3):490-6.
    View in: PubMed
    Score: 0.027
  8. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2011 Aug 15; 188(3):361-5.
    View in: PubMed
    Score: 0.027
  9. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):493-6.
    View in: PubMed
    Score: 0.026
  10. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):106-13.
    View in: PubMed
    Score: 0.024
  11. Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series. J Clin Psychopharmacol. 2008 Aug; 28(4):464-7.
    View in: PubMed
    Score: 0.022
  12. Delay discounting and reward sensitivity in a 2 ? 2 study of bipolar disorder and alcohol dependence. Addiction. 2019 08; 114(8):1369-1378.
    View in: PubMed
    Score: 0.011
  13. Identification and initial validation of empirically derived bipolar symptom states from a large longitudinal dataset: an application of hidden Markov modeling to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study. Psychol Med. 2019 05; 49(7):1102-1108.
    View in: PubMed
    Score: 0.011
  14. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Transl Psychiatry. 2017 07 04; 7(7):e1163.
    View in: PubMed
    Score: 0.010
  15. Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33.
    View in: PubMed
    Score: 0.009
  16. Does alexithymia explain variation in cue-elicited craving reported by methamphetamine-dependent individuals? Am J Addict. 2012 Mar-Apr; 21(2):130-5.
    View in: PubMed
    Score: 0.007
  17. Impaired cognitive performance in subjects with methamphetamine dependence during exposure to neutral versus methamphetamine-related cues. Am J Drug Alcohol Abuse. 2012 May; 38(3):251-9.
    View in: PubMed
    Score: 0.007
  18. The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict. 2011 Sep-Oct; 20(5):447-55.
    View in: PubMed
    Score: 0.007
  19. Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. Am J Addict. 2010 Sep-Oct; 19(5):440-9.
    View in: PubMed
    Score: 0.006
  20. Extinction of drug cue reactivity in methamphetamine-dependent individuals. Behav Res Ther. 2010 Sep; 48(9):860-5.
    View in: PubMed
    Score: 0.006
  21. Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessment. J Clin Psychiatry. 2009 Jul; 70(7):1032-40.
    View in: PubMed
    Score: 0.006
  22. Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials. J Clin Psychiatry. 2008 Jul; 69(7):1057-63.
    View in: PubMed
    Score: 0.005
  23. Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder. J Affect Disord. 2008 Sep; 110(1-2):167-73.
    View in: PubMed
    Score: 0.005
  24. Alcohol use and anxiety: diagnostic and management issues. Am J Psychiatry. 2007 Feb; 164(2):217-21; quiz 372.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.